Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Strata Critical Medical (SRTA) Cash from Operations (2019 - 2025)

Historic Cash from Operations for Strata Critical Medical (SRTA) over the last 7 years, with Q3 2025 value amounting to -$37.3 million.

  • Strata Critical Medical's Cash from Operations fell 68689.22% to -$37.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$42.4 million, marking a year-over-year decrease of 31993.66%. This contributed to the annual value of -$2.5 million for FY2024, which is 9221.31% up from last year.
  • Latest data reveals that Strata Critical Medical reported Cash from Operations of -$37.3 million as of Q3 2025, which was down 68689.22% from -$3.1 million recorded in Q2 2025.
  • Strata Critical Medical's 5-year Cash from Operations high stood at $8.4 million for Q2 2024, and its period low was -$37.3 million during Q3 2025.
  • Its 5-year average for Cash from Operations is -$8.2 million, with a median of -$8.7 million in 2022.
  • Its Cash from Operations has fluctuated over the past 5 years, first tumbled by 365282.41% in 2021, then surged by 21413.74% in 2024.
  • Over the past 5 years, Strata Critical Medical's Cash from Operations (Quarter) stood at -$6.0 million in 2021, then plummeted by 51.33% to -$9.1 million in 2022, then fell by 2.37% to -$9.3 million in 2023, then skyrocketed by 81.2% to -$1.8 million in 2024, then tumbled by 2028.82% to -$37.3 million in 2025.
  • Its last three reported values are -$37.3 million in Q3 2025, -$3.1 million for Q2 2025, and -$246000.0 during Q1 2025.